These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18473788)

  • 1. CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor.
    Vermeire K; Brouwers J; Van Herrewege Y; Le Grand R; Vanham G; Augustijns P; Bell TW; Schols D
    Curr HIV Res; 2008 May; 6(3):246-56. PubMed ID: 18473788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro.
    Vermeire K; Princen K; Hatse S; De Clercq E; Dey K; Bell TW; Schols D
    AIDS; 2004 Nov; 18(16):2115-25. PubMed ID: 15577644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cyclotriazadisulfonamides as new and unique HIV entry inhibitors].
    Vermeire K
    Verh K Acad Geneeskd Belg; 2007; 69(5-6):231-47. PubMed ID: 18351208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity.
    Vermeire K; Lisco A; Grivel JC; Scarbrough E; Dey K; Duffy N; Margolis L; Bell TW; Schols D
    Biochem Pharmacol; 2007 Aug; 74(4):566-78. PubMed ID: 17603023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs.
    Vermeire K; Schols D
    J Antimicrob Chemother; 2005 Aug; 56(2):270-2. PubMed ID: 15980096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus.
    Boadi T; Schneider E; Chung S; Tsai L; Gettie A; Ratterree M; Blanchard J; Neurath AR; Cheng-Mayer C
    AIDS; 2005 Oct; 19(15):1587-94. PubMed ID: 16184027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor.
    Vermeire K; Zhang Y; Princen K; Hatse S; Samala MF; Dey K; Choi HJ; Ahn Y; Sodoma A; Snoeck R; Andrei G; De Clercq E; Bell TW; Schols D
    Virology; 2002 Oct; 302(2):342-53. PubMed ID: 12441078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
    Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
    J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles.
    Neurath AR; Strick N; Jiang S; Li YY; Debnath AK
    BMC Infect Dis; 2002 Apr; 2():6. PubMed ID: 11983022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor.
    Vermeire K; Bell TW; Choi HJ; Jin Q; Samala MF; Sodoma A; De Clercq E; Schols D
    Mol Pharmacol; 2003 Jan; 63(1):203-10. PubMed ID: 12488553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent
    Chong H; Xue J; Xiong S; Cong Z; Ding X; Zhu Y; Liu Z; Chen T; Feng Y; He L; Guo Y; Wei Q; Zhou Y; Qin C; He Y
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques.
    Tsai CC; Emau P; Jiang Y; Tian B; Morton WR; Gustafson KR; Boyd MR
    AIDS Res Hum Retroviruses; 2003 Jul; 19(7):535-41. PubMed ID: 12921090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds.
    Lumangtad LA; Claeys E; Hamal S; Intasiri A; Basrai C; Yen-Pon E; Beenfeldt D; Vermeire K; Bell TW
    Bioorg Med Chem; 2020 Dec; 28(24):115816. PubMed ID: 33181479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.
    Li L; Tan S; Lu H; Lu L; Yang J; Jin H; Liu S; Jiang S
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):384-92. PubMed ID: 21239999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of simian immunodeficiency virus-infected cells in pigtail macaques.
    Winnall WR; Sexton A; Alcantara S; Roath S; De Rose R; Kent SJ
    Virology; 2012 Jun; 428(1):11-20. PubMed ID: 22507218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge.
    Ariën KK; Baleux F; Desjardins D; Porrot F; Coïc YM; Michiels J; Bouchemal K; Bonnaffé D; Bruel T; Schwartz O; Le Grand R; Vanham G; Dereuddre-Bosquet N; Lortat-Jacob H
    Sci Rep; 2016 Oct; 6():34829. PubMed ID: 27721488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
    Wetzel KS; Yi Y; Elliott STC; Romero D; Jacquelin B; Hahn BH; Muller-Trutwin M; Apetrei C; Pandrea I; Collman RG
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unsymmetrical cyclotriazadisulfonamide (CADA) compounds as human CD4 receptor down-modulating agents.
    Demillo VG; Goulinet-Mateo F; Kim J; Schols D; Vermeire K; Bell TW
    J Med Chem; 2011 Aug; 54(16):5712-21. PubMed ID: 21800875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
    Veazey RS; Klasse PJ; Schader SM; Hu Q; Ketas TJ; Lu M; Marx PA; Dufour J; Colonno RJ; Shattock RJ; Springer MS; Moore JP
    Nature; 2005 Nov; 438(7064):99-102. PubMed ID: 16258536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.